If you have been following this blog and keeping up with the fascinating world of regenerative medicine, you know that all adult stem cells are not the same. There are different progenitor cell types like Hematopoietic stem cells (HSCs) and Mesenchymal stem cells (MSCs) that are derived from bone marrow. HSCs give rise to all the cells in the blood, including immune cells like B cells and T cells, through the process of hematopoiesis and here is an excellent review on MSCs and the therapeutic benefits they provide. – Read More –
Alright y’all, let’s get real. Most of us are pretty comfortable with the idea that mesenchymal stem cells (MSCs) can become cartilage, bone, fat, and connective tissue cells (among other awesome properties). Thousands upon thousands of patients’ worth of studies have been published using bone marrow-derived MSCs for everything from avascular necrosis to peripheral artery disease, many of which constitute the most effective, ground-breaking treatments for their respective pathologies. But it’s still not enough, right? If you’re at all like me, you hope to see stem cell technology evolve to the point of keeping spare parts in jars, so we can live in a future where organ donors are an archaic thing of the past. That is just not happening when MSCs can only become a select few cell types. Brace yourselves though: scientists just found a way to change that.
In my previous blog, I talked about the different routes used to deliver stem cells focusing on systemic delivery. Regardless of the delivery route chosen, labeling and tracking stem cells in vivo (within the organism) helps in determining their survival rate, where they migrated to and how many cells were retained in the area of interest. This provides us with insights into the therapeutic benefits of regenerative treatments. In this blog, I will discuss the current techniques being used to label stem cells. – Read More –
This post is written in response to Dr. Peter Diamandis’s “Stem Cells are Poised to Change Health and Medicine Forever.” While this article was informative, I have taken the time to elaborate on some of the topics and discussed some inconsistencies with what we have seen in peer-reviewed scientific articles. – Read More –
Hello readers, it’s Dr. Richard Suzuki again and I’ll be writing today’s Celling blog. I’d like to discuss the recent surge of media attention surrounding antibiotic-resistant bacteria resulting from the unfortunate case of a 70-year old woman who died in Washoe County, Nevada. Dr. Moncivais has discussed the subject of antibiotic-resistant bacteria in a previous blog, but given the renewed discussion over these “superbugs” as they care called, I thought it would be timely to re-address the subject. – Read More –